@Prof_Nick_James presented the Stampede data on upfront abiraterone+ prednisone in mHSPC #asco17 @PCF_Science @ProstateUK @ASCO Improved OS pic.twitter.com/u3uAyCxnLk
BREAKING: Adding #abiraterone to standard treatment improves #prostatecancer survival by almost 40% #ASCO17 https://t.co/2DBBqbArQo 1/2 pic.twitter.com/1ZwvkwNUJw
留言列表